Cargando…
Immunohistochemistry for Myc Predicts Survival in Colorectal Cancer
MYC over-expression as determined by molecular means has been reported as a favorable prognostic biomarker in colorectal carcinoma (CRC). However MYC expression analysis is not available in the routine clinical setting. We investigated whether immunohistochemistry (IHC) for the myc protein using a n...
Autores principales: | Toon, Christopher W., Chou, Angela, Clarkson, Adele, DeSilva, Keshani, Houang, Michelle, Chan, Joseph C. Y., Sioson, Loretta L., Jankova, Lucy, Gill, Anthony J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913591/ https://www.ncbi.nlm.nih.gov/pubmed/24503701 http://dx.doi.org/10.1371/journal.pone.0087456 |
Ejemplares similares
-
BRAFV600E immunohistochemistry in conjunction with mismatch repair status predicts survival in patients with colorectal cancer
por: Toon, Christopher W, et al.
Publicado: (2014) -
A Further Investigation of Combined Mismatch Repair and BRAFV600E Mutation Specific Immunohistochemistry as a Predictor of Overall Survival in Colorectal Carcinoma
por: Luey, Nathan, et al.
Publicado: (2014) -
Succinate Dehydrogenase Deficiency Is Rare in Pituitary Adenomas
por: Gill, Anthony J., et al.
Publicado: (2014) -
Loss of expression of BAP1 is a useful adjunct, which strongly supports the diagnosis of mesothelioma in effusion cytology
por: Andrici, Juliana, et al.
Publicado: (2015) -
Inflammatory Myofibroblastic Tumors of the Female Genital Tract Are Under-recognized: A Low Threshold for ALK Immunohistochemistry Is Required
por: Pickett, Justine L., et al.
Publicado: (2017)